Upadacitinib improves symptoms of concomitant allergic rhinitis or allergic asthma in patients with severe atopic dermatitis: A 16-week multicentre retrospective study.

التفاصيل البيبلوغرافية
العنوان:	Upadacitinib improves symptoms of concomitant allergic rhinitis or allergic asthma in patients with severe atopic dermatitis: A 16-week multicentre retrospective study.
المؤلفون:	Gargiulo L; Dermatology Unit, IRCCS Humanitas Research Hospital, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Milan, Italy., Ibba L; Dermatology Unit, IRCCS Humanitas Research Hospital, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Milan, Italy., Piscazzi F; Dermatology Unit, IRCCS Humanitas Research Hospital, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Milan, Italy., Amoruso F; Dermatology Unit, Azienda Ospedaliera di Cosenza, Cosenza, Italy., Balato A; Dermatology Unit, University of Campania L, Naples, Italy., Barei F; Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Bertello M; Department of Biomedical Science and Human Oncology, Second Dermatologic Clinic, University of Turin, Turin, Italy., Burroni AG; Section of Dermatology, Department of Health Sciences (Di.S.Sal), IRCCS - San Martino Polyclinic Hospital, University of Genoa, Genoa, Italy., Caccavale S; Dermatology Unit, University of Campania L, Naples, Italy., Ferrucci SM; Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Foti C; Section of Dermatology and Venereology, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari 'Aldo Moro', Bari, Italy., Gaiani FM; Department of Dermatology, Dermatology Unit Azienda Ospedaliera San Donato Milanese, Milan, Italy., Girolomoni G; Section of Dermatology and Venereology, Department of Medicine, University of Verona, Verona, Italy., Malagoli P; Department of Dermatology, Dermatology Unit Azienda Ospedaliera San Donato Milanese, Milan, Italy., Marzano AV; Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Maurelli M; Section of Dermatology and Venereology, Department of Medicine, University of Verona, Verona, Italy., Napolitano M; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy., Nettis E; Department of Emergency and Organ Transplantation, School of Allergology and Clinical Immunology, University of Bari Aldo Moro, Bari, Italy., Ortoncelli M; Department of Biomedical Science and Human Oncology, Second Dermatologic Clinic, University of Turin, Turin, Italy., Patruno C; Section of Dermatology, Health Sciences Department, Magna Graecia University, Catanzaro, Italy., Pezzolo E; Department of Dermatology, San Bortolo Hospital, Vicenza, Italy.; A Study Centre of the Italian Group for the Epidemiologic Research in Dermatology (GISED), Bergamo, Italy., Ribero S; Department of Biomedical Science and Human Oncology, Second Dermatologic Clinic, University of Turin, Turin, Italy., Romita P; Section of Dermatology and Venereology, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari 'Aldo Moro', Bari, Italy., Rossi MT; Dermatology Department, University of Brescia, Brescia, Italy., Zaza I; Department of Emergency and Organ Transplantation, School of Allergology and Clinical Immunology, University of Bari Aldo Moro, Bari, Italy., Costanzo A; Dermatology Unit, IRCCS Humanitas Research Hospital, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Milan, Italy., Narcisi A; Dermatology Unit, IRCCS Humanitas Research Hospital, Milan, Italy.
المصدر:	Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2024 Feb 08. Date of Electronic Publication: 2024 Feb 08.
Publication Model:	Ahead of Print
نوع المنشور:	Letter
اللغة:	English
بيانات الدورية:	Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9216037 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-3083 (Electronic) Linking ISSN: 09269959 NLM ISO Abbreviation: J Eur Acad Dermatol Venereol Subsets: MEDLINE
أسماء مطبوعة:	Publication: Oxford : Wiley-Blackwell Original Publication: Amsterdam ; New York : Elsevier Science Publishers, c1992-
References:	Simpson EL, Bieber T, Eckert L, Wu R, Ardeleanu M, Graham NM, et al. Patient burden of moderate to severe atopic dermatitis (AD): insights from a phase 2b clinical trial of dupilumab in adults. J Am Acad Dermatol. 2016;74(3):491-498. https://doi.org/10.1016/j.jaad.2015.10.043. Wollenberg A, Kinberger M, Arents B, Aszodi N, Avila Valle G, Barbarot S, et al. European guideline (EuroGuiDerm) on atopic eczema: part I-systemic therapy. J Eur Acad Dermatol Venereol. 2022;36(9):1409-1431. https://doi.org/10.1111/jdv.18345. European Medicines Agency. Dupixent (dupilumab): summary of product characteristics. 2023 [cited 2023 June 10]. Available from: https://www.ema.europa.eu/en/documents/product-information/dupixent-epar-product-information_it.pdf. European Medicines Agency. Rinvoq (upadacitinib): summary of product characteristics. 2019 [cited 2023 June 10]. https://www.ema.europa.eu/en/medicines/human/EPAR/rinvoq. Gargiulo L, Ibba L, Piscazzi F, Alfano A, Cascio Ingurgio R, Valenti M, et al. Effectiveness and safety of upadacitinib for moderate-to-severe atopic dermatitis in a real-world setting: a 52-week retrospective study. J Eur Acad Dermatol Venereol. 2023;15. https://doi.org/10.1111/jdv.19507. Blauvelt A, Teixeira HD, Simpson EL, Costanzo A, De Bruin-Weller M, Barbarot S, et al. Efficacy and safety of upadacitinib vs dupilumab in adults with moderate-to-severe atopic dermatitis: a randomized clinical trial [published correction appears in JAMA Dermatol. 2022 Feb 1;158(2):219] [published correction appears in JAMA Dermatol. 2022 Feb 1;158(2):219]. JAMA Dermatol. 2021;157(9):1047-1055. https://doi.org/10.1001/jamadermatol.2021.3023. Spekhorst LS, de Graaf M, van der Rijst LP, Zuithoff NPA, Schweizer RC, Kamsteeg M, et al. The positive effect of dupilumab on comorbid asthma in patients with atopic dermatitis. Clin Transl Allergy. 2023;13(1):e12219. https://doi.org/10.1002/clt2.12219. Meltzer EO, Schatz M, Nathan R, Garris C, Stanford RH, Kosinski M. Reliability, validity, and responsiveness of the rhinitis control assessment test in patients with rhinitis. J Allergy Clin Immunol. 2013;131(2):379-386. https://doi.org/10.1016/j.jaci.2012.10.022. Wechsler ME, Ford LB, Maspero JF, Pavord ID, Papi A, Bourdin A, et al. Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study. Lancet Respir Med. 2022;10(1):11-25. https://doi.org/10.1016/S2213-2600(21)00322-2. Betancor D, Valverde-Monge M, Sastre J. Upadacitinib-induced remission of allergic asthma: a case report. J Allergy Clin Immunol Pract. 2021;9(11):4162-4163. https://doi.org/10.1016/j.jaip.2021.06.055.
تواريخ الأحداث:	Date Created: 20240208 Latest Revision: 20240208
رمز التحديث:	20240208
DOI:	10.1111/jdv.19862
PMID:	38329235
قاعدة البيانات:	MEDLINE

View record at Wiley

Full Text Finder

الوصف
تدمد:	1468-3083
DOI:	10.1111/jdv.19862